BIOSPAN
DEAD

Serial Number

98340685

Owner

BioAro inc

Attorney

Steven Fairchild

Filing Date

Jan 3, 2024

Add to watchlist:

No watchlists yet
View on USPTO

BIOSPAN Trademark

Serial Number: 98340685

BIOSPAN is a trademark filed by BioAro inc on January 3, 2024. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

BioAro inc (3 trademarks)

3151 27 St NE #102calgary
Calgary T1Y0B4 , CA

Entity Type: 03

Trademark Details

Filing Date

January 3, 2024

Registration Date

Not Registered

Goods & Services

Pharmaceutical services, namely, processing online and telephone prescription orders in retail and central fill pharmacies.

Medical analysis for the diagnosis and treatment of persons with medical disorders; genetic testing for medical purposes; medical testing services of blood serums to diagnose cardiac biomarkers, lipid composition, red blood cell count, and white blood cell count; metabolic testing for nutraceutical needs; rehabilitation patient care services; mental health counseling with therapy services; preventive services, namely, providing wellness service in the field of health care and weight loss programs; telemedicine services for remote healthcare consultations; home healthcare services; and medical pharmaceutical consultation and prescription refill reminder services.

Application service provider, namely, hosting, managing, developing, analyzing, and maintaining applications, software, and web sites, of others in the fields of healthcare, benefits programs, employee productivity, risk management; Providing on-line, non-downloadable, Internet-based software application for medical billing for physicians and health care institutions; software applications to target treatment based on diseases (i.e., high cholesterol, diabetes, depression, cancer, autoimmune disorders, and chronic pain); providing temporary use of online non-downloadable software for diagnosing high cholesterol, diabetes, depression, cancer, autoimmune disorders and chronic pain; providing temporary use of online non-downloadable software for diagnosing and customizing treatment plans for children with attention deficit hyperactivity disorder (ADHD), autism or anxiety; providing temporary use of online non-downloadable software for customizing healthcare treatment plans for patients; structural and functional analysis of genomes and large intestine microbiomes for patients; blood analysis for scientific research purposes; biochemical research and analysis of blood; consulting services in the field of pharmaceutical research.

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Apr 5, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Apr 5, 2025 ABN2
NOTIFICATION OF FINAL REFUSAL EMAILED
Dec 17, 2024 GNFN
FINAL REFUSAL E-MAILED
Dec 17, 2024 GNFR
FINAL REFUSAL WRITTEN
Dec 17, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 9, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 8, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 8, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 8, 2024 GNRN
NON-FINAL ACTION E-MAILED
Aug 8, 2024 GNRT
NON-FINAL ACTION WRITTEN
Aug 8, 2024 CNRT
ASSIGNED TO EXAMINER
Jul 31, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 19, 2024 NWOS
NEW APPLICATION ENTERED
Jan 3, 2024 NWAP